Additional file 2 of A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping

Wen, QORCID logo; Kim, C; Hamilton, P and Zhang, S (2016). Additional file 2 of A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping. [Dataset]. Figshare. https://doi.org/10.6084/m9.figshare.c.3624356_D2.v1
Copy

Significant drugs returned with the k=50 HDACi gene signature. The list of significant drugs returned from sscMap using the k=50 HDACi gene signature from the "simulated experiment". All 7 known HDAC inhibitors were pulled out, but together with many other drugs, which may or may not related to HDAC inhibition. The main biological theme (HDAC inhibition) could potentially be weakned or even masked due to the co-existence of many other drugs.

Keywords

Connectivity mapping; Differentially expressed genes; Gene signature progression; Disease inhibitory compounds; Lung cancer; Breast cancer

No files available. Please consult associated links.


EndNote BibTeX Reference Manager Refer Atom Dublin Core (with Type as Type) JSON Multiline CSV RDF+XML OPENAIRE RDF+N3 OpenURL ContextObject MODS Data Cite XML Simple Metadata EP3 XML ASCII Citation METS MPEG-21 DIDL OpenURL ContextObject in Span HTML Citation RDF+N-Triples
Export